An Efficacy and Safety Study of Basimglurant in Patients With Trigeminal Neuralgia.
Status:
Recruiting
Trial end date:
2024-05-20
Target enrollment:
Participant gender:
Summary
Trigeminal neuralgia (TN), also called "tic douloureux", is the most common form of
craniofacial neuropathic pain and is considered the cause of one of the most painful
afflictions known in medical practice.
This study is designed to evaluate the efficacy and safety of 1.5mg - 3.5mg basimglurant in
adults with TN.